413 related articles for article (PubMed ID: 29654947)
1. 2018 update of French recommendations on the management of postmenopausal osteoporosis.
Briot K; Roux C; Thomas T; Blain H; Buchon D; Chapurlat R; Debiais F; Feron JM; Gauvain JB; Guggenbuhl P; Legrand E; Lehr-Drylewicz AM; Lespessailles E; Tremollieres F; Weryha G; Cortet B
Joint Bone Spine; 2018 Oct; 85(5):519-530. PubMed ID: 29654947
[TBL] [Abstract][Full Text] [Related]
2. 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis.
Briot K; Cortet B; Thomas T; Audran M; Blain H; Breuil V; Chapuis L; Chapurlat R; Fardellone P; Feron JM; Gauvain JB; Guggenbuhl P; Kolta S; Lespessailles E; Letombe B; Marcelli C; Orcel P; Seret P; Trémollières F; Roux C
Joint Bone Spine; 2012 May; 79(3):304-13. PubMed ID: 22521109
[TBL] [Abstract][Full Text] [Related]
3. French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation.
Briot K; Paccou J; Beuzeboc P; Bonneterre J; Bouvard B; Confavreux CB; Cormier C; Cortet B; Hannoun-Lévi JM; Hennequin C; Javier RM; Lespessailles E; Mayeur D; Mongiat Artus P; Vieillard MH; Debiais F
Joint Bone Spine; 2019 Jan; 86(1):21-28. PubMed ID: 30287350
[TBL] [Abstract][Full Text] [Related]
4. French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies.
Bouvard B; Confavreux CB; Briot K; Bonneterre J; Cormier C; Cortet B; Hannoun-Lévi JM; Hennequin C; Javier RM; Kerbrat P; Lespessailles E; Lesur A; Mayeur D; Paccou J; Trémollières F; Vieillard MH; Debiais F
Joint Bone Spine; 2019 Oct; 86(5):542-553. PubMed ID: 31352137
[TBL] [Abstract][Full Text] [Related]
5. Fracture risk in early postmenopausal women assessed using FRAX.
Trémollieres F; Cochet T; Cohade C; Pouillès JM; Ribot C
Joint Bone Spine; 2010 Jul; 77(4):345-8. PubMed ID: 20605507
[TBL] [Abstract][Full Text] [Related]
6. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.
Trémollieres FA; Chabbert-Buffet N; Plu-Bureau G; Rousset-Jablonski C; Lecerf JM; Duclos M; Pouilles JM; Gosset A; Boutet G; Hocke C; Maris E; Hugon-Rodin J; Maitrot-Mantelet L; Robin G; André G; Hamdaoui N; Mathelin C; Lopes P; Graesslin O; Fritel X
Maturitas; 2022 Sep; 163():62-81. PubMed ID: 35717745
[TBL] [Abstract][Full Text] [Related]
7. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA; Cooper C; Rizzoli R; Reginster JY;
Osteoporos Int; 2019 Jan; 30(1):3-44. PubMed ID: 30324412
[TBL] [Abstract][Full Text] [Related]
8. Management of postmenopausal osteoporosis.
Andreopoulou P; Bockman RS
Annu Rev Med; 2015; 66():329-42. PubMed ID: 25386933
[TBL] [Abstract][Full Text] [Related]
9. How Would You Manage This Patient With Osteoporosis?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Burns RB; Rosen H; Berry S; Smetana GW
Ann Intern Med; 2018 Jun; 168(11):801-808. PubMed ID: 29868815
[TBL] [Abstract][Full Text] [Related]
10. Use of FRAX®-based fracture risk assessments to identify patients who will benefit from osteoporosis therapy.
Silverman SL; Komm BS; Mirkin S
Maturitas; 2014 Nov; 79(3):241-7. PubMed ID: 25124532
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal Osteoporosis: A Clinical Review.
Watts NB
J Womens Health (Larchmt); 2018 Sep; 27(9):1093-1096. PubMed ID: 29583083
[TBL] [Abstract][Full Text] [Related]
12. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic management of osteoporosis.
Fontenot HB; Harris AL
J Obstet Gynecol Neonatal Nurs; 2014; 43(2):236-45; quiz E20-1. PubMed ID: 24502394
[TBL] [Abstract][Full Text] [Related]
14. European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA; McCloskey EV; Johansson H; Cooper C; Rizzoli R; Reginster JY;
Osteoporos Int; 2013 Jan; 24(1):23-57. PubMed ID: 23079689
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal osteoporosis: fracture risk and prevention.
Kaunitz AM; McClung MR; Feldman RG; Wysocki S
J Fam Pract; 2009 Nov; 58(11 Suppl Postmenopausal):S1-6. PubMed ID: 19891943
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
[TBL] [Abstract][Full Text] [Related]
17. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
18. Real-world challenges of treating osteoporosis.
Owens G
Am J Manag Care; 2011 May; 17 Suppl 6():S177-84. PubMed ID: 21882487
[TBL] [Abstract][Full Text] [Related]
19. Extensive undertreatment of osteoporosis in older Swedish women.
Lorentzon M; Nilsson AG; Johansson H; Kanis JA; Mellström D; Sundh D
Osteoporos Int; 2019 Jun; 30(6):1297-1305. PubMed ID: 30805678
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis.
Huang S; Lin H; Zhu X; Chen X; Fan L; Liu C
Endokrynol Pol; 2014; 65(2):96-104. PubMed ID: 24802732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
